All News

Insurers and state Medicaid agencies have been eager to strike a deal with pharmaceutical companies to secure discounts on pricey hepatitis C drugs.

New reports show that 2 big experiments run by the health law's innovation lab delivered mixed early results in enhancing primary care.

Although one of the central features of the Affordable Care Act was eliminating discrimination based on preexisting conditions, there is evidence insurers have found ways to dissuade high-cost patients from enrolling in their plans.

Lawmakers in Wyoming are working toward an agreement that would allow the state to accept hundreds of millions of federal dollars to expand the state's Medicaid program.

A one-minute look back at the week of January 26, 2015, in managed care, including anticipated moves from volume-based to value-based payments and expected push back on cancer drug costs.

California advocates worry that having half its children in Medi-Cal will mean poor access to care. But the real issue may be the growing number of poor children nationwide and the overall effect on Medicaid.

Reports say NIH would receive funds to collect DNA from 1 million volunteers, the National Cancer Institute would get research funds, and FDA would get support to regulate molecular diagnostic tests. The plans need funding from Congress.

The Canadian company Valeant Pharmaceuticals International Inc has reached an agreement to buy the prostate cancer immunotherapy from Dendreon Corp.

The integrated cancer services offered by Sarah Cannon will soon be supported by the personalized medicine technology platform of Syapse, to improve individualized patient care, the companies have announced.

The Office of the National Coordinator for Health Information Technology has released the first draft of its interoperability roadmap to deliver better care through the exchange and use of health information technology.

The CDC report found that patients on high cost prescription medications ask their physician for low-cost alternatives, but cheaper medications from outside the Unites States, skip doses, or delay refills to save cost.

Mobile health (mHealth) can be so much more than smartphone apps, and it is a growing movement in the United States that can empower patients, providers, and payers, according to Meg Maley, RN, BSN, founder and CEO of CanSurround.

Karen B. DeSalvo, MD, MPH, MSc, announced the appointment of a new chief medical officer at the Office of the National Coordinator for Health Information Technology in a note to staff.

After calls for changes and more flexibility from physician groups, CMS announced it intends to modify requirements to meet meaningful use in the Medicare and Medicaid Electronic Health Record Incentive Programs.

The drug, jointly developed by Pharmacyclics and Janssen Biotech, has received prior approvals for 3 other indications.

Perceptions of drug costs may affect how much patients benefit from the drug, according to a study treating participants with a placebo. The results were published in the online issue of Neurology.

The Genetic Information Nondiscrimination Act (GINA) protects most consumers from losing health coverage or their job if they pursue genetic testing. But authors of a new article in The New England Journal of Medicine explore the implications of testing for life, disability and long-term care insurance.

Smokers diagnosed with prostate cancer who were treated with radiation were at a greater risk of their cancer returning, metastasizing, and ultimately causing death. Former smokers, however, did not have the increased risk.

Of the 944,000 people who could renew their coverage for 2015 through Covered California, the state's health insurance exchange, 94% stayed in the same plan that they were in last year.

PACE has launched an evidence-based online tool, Continuous Online Indicators, which will provide information on research progress in 12 tumor types.

Meeting enrollment goals for the Affordable Care Act proved the easy part for the HHS in 2015. The hard part will come March 4, 2015, when the US Supreme Court will hear a case that could eliminate financial subsidies for millions who signed up, putting their health coverage at risk.

A new private-sector alliance of healthcare systems and payers will dedicate to accelerate the US healthcare system's transition to value-based models aligned with improving outcomes and lowering costs.

A new health policy issue brief from the Brookings Institution has outlined specific modifications that would enable to legislation in Congress to support better care and more value in Medicare.

Kyprlois is currently approval for use in multiple myeloma patients who have progressed on 2 prior therapies.

The White House said a Republican lawsuit challenging its implementation of the 2010 healthcare law misunderstands the constitutional separation of powers and should be thrown out.

Screening for deadly illnesses does not necessarily save lives despite assumptions otherwise, according to a study published in the International Journal of Epidemiology.

Although the Affordable Care Act (ACA) was signed into law more than 4 years ago, many aspects of it are fairly new, which makes it difficult to analyze the impact the law has had on the United States healthcare system.

After Steven Miller, CMO at Express Scripts, announced last week that his company would like to influence the oncology market, Pharma seems to have paid heed.

Targeted biopsy using new fusion technology that combines magnetic resonance imaging (MRI) with ultrasound is more effective than standard biopsy in detecting high-risk prostate cancer, according to a large-scale study.

Although there have been some accusations of "cookbook medicine" with regards to measurement guidelines, panelists Dennis Scanlon, PhD, Jess DeMartino, PhD, Phyllis Torda, and Laura Long, MD, do see progress to remedy the situation and make guidelines more effective.